Evaxion A (EVAX) Total Current Liabilities (2019 - 2025)
Evaxion A posted quarterly Total Current Liabilities of $4.3 million for Q4 2025, down 2.54% year-on-year from $4.4 million in Q4 2024, and down 20.01% on a QoQ basis from $5.3 million in Q2 2025.
Evaxion A (EVAX) has 7 years of Total Current Liabilities data on file, last reported at $4.3 million in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities fell 2.54% year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2025 stood at $4.3 million (down 2.54% YoY), and the FY2025 full-year result was $4.3 million, down 2.54% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $4.3 million, down from $5.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $7.1 million in Q4 2023 and bottomed at $3.8 million in Q4 2022.
- The 5-year median for Total Current Liabilities is $4.4 million (2024), against an average of $4.7 million.
- The widest annual swing landed in 2023, when Total Current Liabilities jumped 88.3%; it then slumped 38.34% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $4.3 million in 2021, then retreated by 12.98% to $3.8 million in 2022, then surged by 88.3% to $7.1 million in 2023, then plunged by 38.34% to $4.4 million in 2024, then decreased by 2.54% to $4.3 million in 2025.
- The last three Total Current Liabilities figures came in at $4.3 million (Q4 2025), $5.3 million (Q2 2025), and $4.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 289.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.26 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Dec 31, 2023 | 7.08 Mn |
| Jun 30, 2023 | 4.05 Mn |
| Dec 31, 2022 | 3.76 Mn |
| Jun 30, 2022 | 4.41 Mn |
| Mar 31, 2022 | 4.69 Mn |
| Dec 31, 2021 | 4.32 Mn |
| Sep 30, 2021 | 3.92 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 6.02 Mn |
| Dec 31, 2020 | 4.93 Mn |
| Dec 31, 2019 | 1.72 Mn |